|1.||Muenke, Maximilian: 2 articles (06/2013 - 01/2011)|
|2.||Arcos-Burgos, Mauricio: 2 articles (06/2013 - 01/2011)|
|3.||Hutz, M H: 1 article (06/2015)|
|4.||Tovo-Rodrigues, L: 1 article (06/2015)|
|5.||Bruxel, E M: 1 article (06/2015)|
|6.||Salatino-Oliveira, A: 1 article (06/2015)|
|7.||Akutagava-Martins, G C: 1 article (06/2015)|
|8.||Polanczyk, G V: 1 article (06/2015)|
|9.||Arcos-Burgos, M: 1 article (06/2015)|
|10.||Chazan, R: 1 article (06/2015)|
|1.||Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/01/2011 - "The findings of a recent study associate LPHN3, a member of the latrophilin family, with an increased risk of developing attention deficit/hyperactivity disorder (ADHD), the most common psychiatric disorder in childhood and adolescence. "
06/01/2013 - "Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD)."
06/01/2015 - "Latrophilin 3 (LPHN3) is a brain-specific member of the G-protein coupled receptor family associated to both attention-deficit/hyperactivity disorder (ADHD) genetic susceptibility and methylphenidate (MPH) pharmacogenetics. "
|2.||Breast Neoplasms (Breast Cancer)
03/01/2000 - "alpha-Latrotoxin interaction with a fusion construct composed of the extracellular domain of CIRL-1 anchored to the membrane by the transmembrane domain of vesicular stomatitis virus glycoprotein, and with neurexin 1alpha, an alpha-latrotoxin receptor structurally unrelated to CIRL-1, produced channels virtually identical with those observed with wild-type CIRL-1. "
|4.||Genetic Predisposition to Disease (Genetic Predisposition)
|1.||GTP-Binding Proteins (G-Protein)
|2.||Epidermal Growth Factor (EGF)